Cargando…

Alzheimer’s disease and epilepsy: An increasingly recognized comorbidity

Both Alzheimer’s disease (AD) and epilepsy are common chronic diseases in older people. Seizures and epileptiform discharges are very prevalent in AD and can occur since any stage of AD. Increasing evidence indicates that AD and epilepsy may be comorbid. Several factors may be related to the underly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fei, Chen, Liling, Yu, Yanying, Xu, Tingwan, Chen, Lu, Yang, Wenqian, Wu, Qian, Han, Yanbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685172/ https://www.ncbi.nlm.nih.gov/pubmed/36438002 http://dx.doi.org/10.3389/fnagi.2022.940515

Ejemplares similares

Alzheimer’s disease and epilepsy: The top 100 cited papers
por: Zhang, Gui-Fen, et al.
Publicado: (2022)

A Systematic Analysis on the Genes and Their Interaction Underlying the Comorbidity of Alzheimer's Disease and Major Depressive Disorder
por: Guo, Pan, et al.
Publicado: (2022)

Aberrant Modulations of Neurocognitive Network Dynamics in Migraine Comorbid With Tinnitus
por: Lan, Liping, et al.
Publicado: (2022)

The effect of physical activity on white matter integrity in aging and prodromal to mild Alzheimer’s disease with vascular comorbidity
por: Konwar, Srijan, et al.
Publicado: (2023)

Early increase of cerebrospinal fluid 14-3-3ζ protein in the alzheimer's disease continuum
por: Lu, Yuanyuan
Publicado: (2022)

Intrinsic Brain Activity of Inferior Temporal Region Increased in Prodromal Alzheimer's Disease With Hearing Loss
por: Hong, Luwei, et al.
Publicado: (2022)

The cognitive dysfunction of claustrum on Alzheimer’s disease: A mini-review
por: Chen, Chun-Yan, et al.
Publicado: (2023)

Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer’s disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea
por: Cumbo, Eduardo, et al.
Publicado: (2023)

Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
por: Lu, Ranran, et al.
Publicado: (2022)

Somatic comorbidity and the progression of cognitive impairment
por: Bidzan, Leszek, et al.
Publicado: (2023)

Gray matter reduction is associated with cognitive dysfunction in depressed patients comorbid with subclinical hypothyroidism
por: Zhao, Shuai, et al.
Publicado: (2023)

Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Chen, Yanru, et al.
Publicado: (2022)

Small-molecule drugs development for Alzheimer's disease
por: Yao, Weiwei, et al.
Publicado: (2022)

Increased functional connectivity patterns in mild Alzheimer’s disease: A rsfMRI study
por: Penalba-Sánchez, Lucía, et al.
Publicado: (2023)

Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers
por: Li, Qiaojun, et al.
Publicado: (2022)

Editorial: Progress of Translational Medicine in Alzheimer's Disease
por: Zhang, Can, et al.
Publicado: (2022)

A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease
por: Chen, Huiyi, et al.
Publicado: (2022)

Precision Repetitive Transcranial Magnetic Stimulation Over the Left Parietal Cortex Improves Memory in Alzheimer’s Disease: A Randomized, Double-Blind, Sham-Controlled Study
por: Jia, Yanli, et al.
Publicado: (2021)

Blood-brain barrier dysfunction and Alzheimer’s disease: associations, pathogenic mechanisms, and therapeutic potential
por: Chen, Yanting, et al.
Publicado: (2023)

Mendelian randomization analyses of smoking and Alzheimer’s disease in Chinese and Japanese populations
por: Zhu, Yuan, et al.
Publicado: (2023)

Effects of rTMS treatment on global cognitive function in Alzheimer's disease: A systematic review and meta-analysis
por: Zhang, Tianjiao, et al.
Publicado: (2022)

Combined Multi-Atlas and Multi-Layer Perception for Alzheimer's Disease Classification
por: Hong, Xin, et al.
Publicado: (2022)

Identification of Immune Hub Genes Associated With Braak Stages in Alzheimer’s Disease and Their Correlation of Immune Infiltration
por: Qian, Xiao-hang, et al.
Publicado: (2022)

Changes in Serum Cystatin C Levels and the Associations With Cognitive Function in Alzheimer's Disease Patients
por: Chen, Xueping, et al.
Publicado: (2022)

Altered functional association and couplings: Effective diagnostic neuromarkers for Alzheimer’s disease
por: Zhao, Chongyi, et al.
Publicado: (2022)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Differential Abnormality in Functional Connectivity Density in Preclinical and Early-Stage Alzheimer's Disease
por: Song, Yu, et al.
Publicado: (2022)

Radiomic Features of the Hippocampus for Diagnosing Early-Onset and Late-Onset Alzheimer’s Disease
por: Du, Yang, et al.
Publicado: (2022)

Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease
por: Gu, Xuefeng, et al.
Publicado: (2022)

Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer’s disease
por: Ma, Xiaoying, et al.
Publicado: (2022)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

Benefits of dietary polyphenols in Alzheimer’s disease
por: El Gaamouch, Farida, et al.
Publicado: (2022)

Neuropsychiatric Symptoms Mediated the Relationship Between Odor Identification and Cognition in Alzheimer's Disease Spectrum: A Structural Equation Model Analysis
por: Wang, Qiang, et al.
Publicado: (2022)

Corrigendum: Selenomethionine Improves Mitochondrial Function by Upregulating Mitochondrial Selenoprotein in a Model of Alzheimer's Disease
por: Chen, Chen, et al.
Publicado: (2021)

Impact prediction of translocation of the mitochondrial outer membrane 70 as biomarker in Alzheimer's disease
por: Cao, Xi, et al.
Publicado: (2022)

Exploration of novel biomarkers in Alzheimer’s disease based on four diagnostic models
por: Zou, Cuihua, et al.
Publicado: (2023)

An explainable machine learning based prediction model for Alzheimer's disease in China longitudinal aging study
por: Yue, Ling, et al.
Publicado: (2023)

Plasma tau proteins for the diagnosis of mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
por: Chen, Leian, et al.
Publicado: (2022)

The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis
por: Li, Jiaxuan, et al.
Publicado: (2023)

An integrated neuroimaging-omics approach for the gut-brain communication pathways in Alzheimer’s disease
por: Sheng, Can, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ai8evan961eu51th46kl0uqpjd